Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Cencora

Close the acquisition of PharmaLex Holding GmbH

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
12 Sep 2022
Due
31 Mar 2023
Delivered
1 Jan 2023
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The transaction is expected to close by March 2023 and is subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals.”
  • SourceCencora Form 8-K press release, 2022-09-12
  • FilingSEC filing index
  • Deadline as statedby March 2023
  • Deadline used31 Mar 2023, the last day of the stated period
  • TypeTransaction
  • Permanent referenceKI-C-2022-COR-005504
    Cite as https://keptindex.org/c/KI-C-2022-COR-005504/ — this address never changes.

What we found

Evidence strength A What the grades mean

Later filings state Cencora acquired and assumed control of PharmaLex effective January 1, 2023, before the March 2023 deadline.

  • A
    Cencora 10-Q filed 2023-08-02 Regulatory filing · published 2 Aug 2023 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint bb1acfc68131
    “The Company acquired and assumed control of PharmaLex Holding Gmbh ("PharmaLex") effective January 1, 2023 for $1.473 billion, subject to customary adjustments, including a $29.3 million cash holdback.” ✓ confirmed on the page
  • A
    Cencora 10-K filed 2023-11-21 Regulatory filing · published 21 Nov 2023 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint d20e86caf168
    “We acquired and assumed control of PharmaLex Holding GmbH ("PharmaLex") effective January 1, 2023 for $1.473 billion.” ✓ confirmed on the page

Market reaction: the shares moved +0.1% against the S&P 500 over the three sessions around the disclosure (1 Aug 2023 to 4 Aug 2023). What this measures

Checked 10 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Acquisition close
Indicative materiality
High rules
Action
Close
Deliverable
acquisition of PharmaLex Holding GmbH
Where
Germany
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: satisfaction of customary closing conditions; receipt of required regulatory approvals
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Cencora? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2022-COR-005504 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.